Affinity Asset Advisors, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773195

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 108 positions · Total reported value $2.08B · Top-10 concentration 41.7% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 24 new · 29 cut · 20 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.1% · vs SPY -14.3% · Prev Value $2.08B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.2% · vs SPY -4.3% · Latest Value $2.15B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Affinity Asset Advisors, LLC disclosed 108 equity positions with a combined reported value of $2.08B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were ROIV ($132.71M), APGE ($131.00M), SYRE ($113.56M). By sector, the heaviest allocations are Health Care 87.6%, Financials 1.3%. Versus the prior quarter, allocation shifted toward Health Care (+11.6pp) and away from Other (-12.0pp).

Versus the prior quarter, Affinity Asset Advisors, LLC opened 24 new positions, trimmed 29 and fully exited 20, a turnover rate of 55.3% of positions. The portfolio's overlap with the prior quarter was 74% of names.

The largest new positions opened in Q2 2026 were TRAX ($40.88M), ARKG ($31.55M), LLY ($23.99M).

Of the 20 positions fully exited versus the prior quarter, the largest were SPY ($130.07M), CNTA ($55.61M), ACLX ($41.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • TRAX FIRST TRACKS BIOTHERAPEUTICS · $40.88M
  • ARKG ARK ETF TR · $31.55M
  • LLY ELI LILLY & CO · $23.99M
  • IDYA IDEAYA BIOSCIENCES INC · $14.91M
  • ODTX ODYSSEY THERAPEUTICS INC · $14.34M
  • EVMN EVOMMUNE INC · $6.65M
  • ASMB ASSEMBLY BIOSCIENCES INC · $5.22M
  • COAG HEMAB THERAPEUTICS HLDGS INC · $5.07M

Fully Exited (vs previous quarter)

  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $130.07M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $55.61M
  • ACLX ARCELLX INC · prev qtr: $41.65M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $29.66M
  • BMY BRISTOL-MYERS SQUIBB CO · prev qtr: $18.20M
  • BBIO BRIDGEBIO PHARMA INC · prev qtr: $11.14M
  • WVE WAVE LIFE SCIENCES INC · prev qtr: $10.16M
  • IBRX IMMUNITYBIO INC · prev qtr: $9.59M

Insider Transactions (Form 4)

Latest Affinity Asset Advisors, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Affinity Asset Advisors, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 108 US equity positions with a combined value of $2.08B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-120744 (status: Approved), registered 2021-04-09
  • Regulatory AUM (Form ADV): $2.45B as of 2026-07-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: affinityadv.com

Portfolio Structure

  • 108 positions · $2.08B reported value (Q2 2026)
  • Top 10 holdings = 41.7% of reported value
  • Largest position: ROIV (ROIVANT SCIENCES LTD) at 6.4%
  • Average position size: $19.25M

Sector Tilt

  • Health Care 87.6%
  • Financials 1.3%
  • Materials 0.3%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 19 new, 34 added, 31 reduced, 12 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.6%
Financials 1.3%
Materials 0.3%
Other 10.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.75M $132.71M 6.38%
6.38%
Add
2 987.00K $131.00M 6.30%
6.30%
Reduce
3 1.28M $113.56M 5.46%
5.46%
Hold
4 1.59M $96.27M 4.63%
4.63%
Reduce
5 5.25M $96.18M 4.63%
4.63%
Reduce
6 650.00K $69.30M 3.33%
3.33%
Add
7 185.00K $61.94M 2.98%
2.98%
Add
8 590.00K $56.15M 2.70%
2.70%
Add
9 826.11K $55.76M 2.68%
2.68%
Reduce
10 2.90M $53.59M 2.58%
2.58%
Add
11 550.00K $46.85M 2.25%
2.25%
Reduce
12 250.00K $46.82M 2.25%
2.25%
Add
13 330.00K $43.98M 2.12%
2.12%
Reduce
14 2.03M $40.88M 1.97%
1.97%
New
15 400.00K $38.99M 1.88%
1.88%
Add
16 1.17M $38.93M 1.87%
1.87%
Add
17 275.00K $33.96M 1.63%
1.63%
Reduce
18 1.80M $33.57M 1.61%
1.61%
Reduce
19 475.00K $33.26M 1.60%
1.60%
Reduce
20 750.00K $31.55M 1.52%
1.52%
New
21 10.14M $27.29M 1.31%
1.31%
Reduce
22 5.81M $27.03M 1.30%
1.30%
Add
23 700.00K $26.05M 1.25%
1.25%
Add
24 165.00K $25.41M 1.22%
1.22%
Add
25 500.00K $25.38M 1.22%
1.22%
Reduce
26 1.15M $24.34M 1.17%
1.17%
Add
27 20.00K $23.99M 1.15%
1.15%
New
28 967.62K $23.47M 1.13%
1.13%
Hold
29 850.00K $22.43M 1.08%
1.08%
Add
30 40.00K $21.48M 1.03%
1.03%
Reduce
31 172.12K $21.10M 1.01%
1.01%
Hold
32 750.00K $20.23M 0.97%
0.97%
Hold
33 1.05M $19.65M 0.94%
0.94%
Add
34 2.50M $19.31M 0.93%
0.93%
Add
35 840.35K $18.67M 0.90%
0.90%
Add
36 300.00K $17.04M 0.82%
0.82%
Hold
37 875.76K $15.95M 0.77%
0.77%
Add
38 2.51M $15.47M 0.74%
0.74%
Hold
39 400.00K $14.91M 0.72%
0.72%
New
40 4.21M $14.37M 0.69%
0.69%
Add
41 766.35K $14.34M 0.69%
0.69%
New
42 11.00M $13.65M 0.66%
0.66%
Add
43 1.25M $13.30M 0.64%
0.64%
Hold
44 4.10M $13.12M 0.63%
0.63%
Add
45 250.00K $13.10M 0.63%
0.63%
Reduce
46 148.01K $12.70M 0.61%
0.61%
Add
47 972.00K $12.67M 0.61%
0.61%
Add
48 374.00K $12.67M 0.61%
0.61%
Reduce
49 100.00K $12.29M 0.59%
0.59%
Add
50 150.00K $12.23M 0.59%
0.59%
Reduce

FAQ

What did Affinity Asset Advisors, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Affinity Asset Advisors, LLC reported 108 equity positions worth $2.08B in aggregate; its largest disclosed positions were ROIV ($132.71M), APGE ($131.00M), SYRE ($113.56M).

How large is Affinity Asset Advisors, LLC's portfolio?

Affinity Asset Advisors, LLC reported $2.08B of long equity holdings across 108 positions as of 2026-Q2. Top-10 holdings account for 41.7% of reported value.

What is Affinity Asset Advisors, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/affinity-asset-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →